333例肺结核病患者不规则治疗原因与转归分析

中国防痨杂志 ›› 2006, Vol. 28 ›› Issue (6): 379-381.

333例肺结核病患者不规则治疗原因与转归分析

李向群；梅建；夏珍；

上海市疾病预防控制中心上海 200336；

出版日期:2006-06-10 发布日期:2006-11-03

Analysis on causes and outcomes of irregular treatment of 333 pulmonary tuberculosis patients

Li Xiangqun,Mei Jian,Xia Zhen.

Shanghai Municipal Center for Disease Control and Prevention,Shanghai 200336,China

Online:2006-06-10 Published:2006-11-03

摘要/Abstract

摘要： 目的了解肺结核病患者不规则治疗的原因和转归,探讨提高病人治疗的依从性和治愈率。方法比较上海市2001—2003年333例不规则治疗肺结核病患者的性别、年龄,对不规则治疗原因进行排序分析。结果不规则治疗的肺结核病患者与同期新登记结核病人性别比男性多于女性(χ²=12.5,P<0.001);不规则治疗原因中以药物不良反应(64.3%)及不配合(26.7%)为主;初治菌阳病人治愈率略高于复治菌阳病人治愈率(χ²=0.077,P>0.05)。结论采用合理的化疗方案,加强对重点病例(尤其是男性、高龄、菌阳病人)的督导管理,妥善处理药物不良反应,将减少病人的不规则治疗率,提高肺结核病例的治愈率。

关键词: 结核,肺/药物疗法, 预后

Abstract: Objective To find out the causes and outcomes of irregular treatment of pulmonary tuberculosis cases,and to discuss the Methods to improve the compliance and increased cure rate. Methods The sex and age of 333 pulmonary tuberculosis cases with irregular treatment during 2001 to 2003 in Shanghai were compared and the causes of irregular treatment were analyzed. Result The male pulmonary tuberculosis cases of irregular treatment are higher than female cases(χ²=12.5,P<0.001).The causes of irregular treatment mainly include adverse drug effects(64.3%) and noncooperation(26.7%).The cure rate of new smear positive cases was slightly higher than retreatment smear positive cases.(χ²=0.077,P>0.05). Conclusion To reduce the irregular treatment and increase cure rate,the reasonable treatment regimen should be used,supervision and management to the priority cases(male,old,smear positive) should be strengthened and the adverse drug effects should be managed properly.

Key words: Pulmonary tuberculosis/chemotherapy, Prognosis

李向群,梅建,夏珍,. 333例肺结核病患者不规则治疗原因与转归分析[J]. 中国防痨杂志, 2006, 28(6): 379-381.

Li Xiangqun,Mei Jian,Xia Zhen.. Analysis on causes and outcomes of irregular treatment of 333 pulmonary tuberculosis patients[J]. Chinese Journal of Antituberculosis, 2006, 28(6): 379-381.

[1]	陈娟, 毛毅, 陈洪德. 30例危重症肺结核孕产妇的临床特征及预后分析[J]. 中国防痨杂志, 2020, 42(6): 638-640.
[2]	杨汝铃, 龙晓茹, 张祯祯, 郑改焕, 赵瑞秋, 许红梅. 222例儿童结核性脑膜炎的临床特征及其预后影响因素分析[J]. 中国防痨杂志, 2020, 42(10): 1053-1060.
[3]	黄威,安雪梅,刘旭晖,裴宁,刘萍,夏露,李涛,席秀红,黄琴,卢水华. 164例结核性脑膜炎患者预后影响因素分析[J]. 中国防痨杂志, 2019, 41(6): 632-639.
[4]	王曼知,陈芳,危松青,周海依,胡锦跃,谢和宾,张小佛,李嘉,石家云,吴蕾. 结核性脑膜炎伴意识障碍患者的预后影响因素分析[J]. 中国防痨杂志, 2019, 41(11): 1203-1210.
[5]	姚琳,席向宇,王霞芳,沈兴华,张建平,叶志坚,施美华,吴妹英,唐佩军. HIV阴性结核性脑膜炎患者预后影响因素分析[J]. 中国防痨杂志, 2019, 41(1): 31-35.
[6]	吴桂辉,黄涛,程耀,黄晓秋,傅小燕,马瑶,李鹏,何畏. HIV感染并发结核性脑膜炎患者的临床特征及其预后影响因素分析[J]. 中国防痨杂志, 2019, 41(1): 18-23.
[7]	葛燕萍,张少俊,姚岚,何娅,范琳. 耐药肺结核患者化疗后发生药物性肝损伤的临床特点分析[J]. 中国防痨杂志, 2018, 40(8): 800-804.
[8]	韦金涛,李华,邱恩明. 结核病的代谢组学研究进展[J]. 中国防痨杂志, 2018, 40(11): 1226-1230.
[9]	李雪莲张立群吴晓光马丽萍高孟秋董伟杰. 五例脊柱结核截瘫合并结核性脑膜炎患者的临床分析及手术时机对预后的影响 [J]. 中国防痨杂志, 2015, 37(9): 938-942.
[10]	任斐，李冬，周倩倩，苟超伦，薛欣. 影响儿童结核性脑膜炎患者近期预后的相关因素分析[J]. 中国防痨杂志, 2014, 36(11): 930-935.
[11]	邓国防，雷建平，邓群，吴于青. 抗结核药物致超敏反应32例临床分析[J]. 中国防痨杂志, 2014, 36(1): 21-24.
[12]	陈晶张军吴小娥黄楠左振华韩光樊水平. 早期骶髂关节结核的诊断及治疗[J]. 中国防痨杂志, 2013, 35(5): 322-325.
[13]	刘彦轩贾安奎郭盛菊石太新尚好珍. 荧光定量PCR技术对前驱期小儿结核性脑膜炎的应用价值[J]. 中国防痨杂志, 2012, 34(5): 280-283.
[14]	陈雪林,徐玉华,黄勇军,李翔,姚锐,樊燕琴,郭丽萍. 40例老年SARS临床分析[J]. 中国防痨杂志, 2004, 26(1): 48-49.